Example #1: As of February 8, 2010, no shareholder beneficially owned more than 5 % of any class of shares of any Fund, except as provided in Appendix B.
Expected output: 'entities: []'

Example #2: Kelly to timely file said forms 3 and 4 was inadvertent.
Expected output: 'entities: [{'span': 'Kelly', 'entity': 'Person'}, {'span': 'forms 3 and 4', 'entity': 'Miscellaneous'}]'

Example #3: If a communication does not indicate a specific Board Member, it will be sent to the Independent Chairman and the outside counsel to the Independent Board Members for further distribution as deemed appropriate by such persons.
Expected output: 'entities: []'

Example #4: While certain U.S. Government-sponsored agencies (such as the Federal Home Loan Mortgage Corporation and the Federal National Mortgage Association) may be chartered or sponsored by acts of Congress, their securities are neither issued nor guaranteed by the U.S. Risks of Repurchase Agreements and Reverse Repurchase Agreements.
Expected output: 'entities: [{'span': 'U.S.', 'entity': 'Location'}, {'span': 'Federal Home Loan Mortgage Corporation', 'entity': 'Government'}, {'span': 'Federal National Mortgage Association', 'entity': 'Government'}, {'span': 'Congress', 'entity': 'Government'}]'

Example #5: On June 15, 2009, the Ninth Circuit denied Chase USA s motion for rehearing en banc.
Expected output: 'entities: [{'span': 'Ninth Circuit', 'entity': 'Court'}, {'span': 'Chase USA', 'entity': 'Business'}]'

Example #6: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #7: Investors may obtain a free copy of the proxy statement, as well as other filings containing information about Chemical Financial and OAK, free of charge from the SEC's website (www.sec.gov); by contacting Chemical Financial Corporation, 333 East Main Street, PO Box 569, Midland, MI 48640-0569, Attention: Ms. Lori A. Gwizdala, Investor Relations, telephone 800-867-9757 or by contacting O.A.K. Financial Corporation, 2445 84th Street, SW, Byron Center, MI 49315, Attention: Mr. James A. Luyk, Investor Relations, telephone 616-599-7419.
Expected output: 'entities: [{'span': 'Chemical Financial', 'entity': 'Business'}, {'span': 'OAK', 'entity': 'Business'}, {'span': 'SEC', 'entity': 'Government'}, {'span': 'Chemical Financial Corporation', 'entity': 'Business'}, {'span': 'East Main Street', 'entity': 'Location'}, {'span': 'Midland', 'entity': 'Location'}, {'span': 'MI', 'entity': 'Location'}, {'span': 'Lori A. Gwizdala', 'entity': 'Person'}, {'span': 'O.A.K. Financial Corporation', 'entity': 'Business'}, {'span': '84th Street, SW', 'entity': 'Location'}, {'span': 'Byron Center', 'entity': 'Location'}, {'span': 'James A. Luyk', 'entity': 'Person'}]'

Example #8: The committee also selects, retains, evaluates and may replace each Fund s independent registered public accounting firm.
Expected output: 'entities: []'

Example #9: The names of the persons filing this statement on Schedule 13D are: MAK Capital One LLC, a Delaware limited liability company (“ MAK Capital ”), MAK Capital Fund LP, a Bermuda limited partnership (“ MAK Fund ”), MAK-ro Capital Master Fund LP (“ MAK-ro Fund ”), a Cayman Islands limited partnership, Michael A. Kaufman (“ Mr. Kaufman ”), Paloma International L.P., a Delaware limited partnership (`` Paloma ''), and S. Donald Sussman (“ Mr. Sussman, ” and collectively, the `` Reporting Persons '').
Expected output: 'entities: [{'span': 'Schedule 13D', 'entity': 'Miscellaneous'}, {'span': 'MAK Capital One LLC', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}, {'span': 'MAK Capital', 'entity': 'Business'}, {'span': 'MAK Capital Fund LP', 'entity': 'Business'}, {'span': 'Bermuda', 'entity': 'Location'}, {'span': 'MAK Fund', 'entity': 'Business'}, {'span': 'MAK-ro Capital Master Fund LP', 'entity': 'Business'}, {'span': 'MAK-ro Fund', 'entity': 'Business'}, {'span': 'Cayman Islands', 'entity': 'Location'}, {'span': 'Michael A. Kaufman', 'entity': 'Person'}, {'span': 'Kaufman', 'entity': 'Person'}, {'span': 'Paloma International L.P.', 'entity': 'Business'}, {'span': 'Paloma', 'entity': 'Business'}, {'span': 'S. Donald Sussman', 'entity': 'Person'}, {'span': 'Sussman', 'entity': 'Person'}]'

Example #10: Board Members Amboian, Kundert and Toth were last elected as Class II Board Members at the annual meeting of shareholders held on June 30, 2008.
Expected output: 'entities: [{'span': 'Amboian', 'entity': 'Person'}, {'span': 'Kundert', 'entity': 'Person'}, {'span': 'Toth', 'entity': 'Person'}]'

Example #11: In October, 2010, the FASB issued ASU 2010-26, Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts.
Expected output: 'entities: [{'span': 'FASB', 'entity': 'Government'}, {'span': 'ASU', 'entity': 'Legislation/Act'}, {'span': 'Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts', 'entity': 'Miscellaneous'}]'

Example #12: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #13: The inspectors of election will treat abstentions and broker non-votes (i.e., shares held by brokers or nominees, typically in street name, as to which (i) instructions have not been received from the beneficial owners or persons entitled to vote and (ii) the broker or nominee does not have discretionary voting power on a particular matter) as present for purposes of determining a quorum.
Expected output: 'entities: []'

Example #14: Morgan Securities executed on June 17, 2011, a Consent of Defendant J.P. Morgan Securities (the “ Consent ”), in which J.P. Morgan Securities neither admitted nor denied any of the allegations (except as to personal and subject matter jurisdiction) in a complaint filed by the Commission, but in which it consented to the entry of a final judgment (“ Final Judgment ”) against it by the United States District Court for the Southern District of New York (the “ Court ”).
Expected output: 'entities: [{'span': 'Morgan Securities', 'entity': 'Business'}, {'span': 'J.P. Morgan Securities', 'entity': 'Business'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #15: Management did not renew four mineral claims, collectively named the “ BARD 1-4 Property, ” situated in the Paymaster Canyon area of Esmeralda County in west-central Nevada.
Expected output: 'entities: [{'span': 'BARD 1-4 Property', 'entity': 'Miscellaneous'}, {'span': 'Paymaster Canyon', 'entity': 'Location'}, {'span': 'Esmeralda County', 'entity': 'Location'}, {'span': 'Nevada', 'entity': 'Location'}]'

Example #16: Except for the Funds, Audit Committee members shall not serve simultaneously on the audit committees of more than two other public companies.
Expected output: 'entities: []'

Example #17: Officers receive no compensation from the Funds.
Expected output: 'entities: []'

Example #18: Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.
Expected output: 'entities: [{'span': 'accounting principles generally accepted', 'entity': 'Legislation/Act'}, {'span': 'United States of America', 'entity': 'Location'}]'

Example #19: Premium was September 30, 2009.
Expected output: 'entities: []'

Example #20: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, James Altucher, Chairman of the Board of Directors and President of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'James Altucher', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

